These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9636617)

  • 21. Antiproliferative effect of rapamycin on growth factor-stimulated human adult lung fibroblasts in vitro may explain its superior efficacy for prevention and treatment of allograft obliterative airway disease in vivo.
    Nair RV; Huang X; Shorthouse R; Adams B; Brazelton T; Braun-Dullaeus R; Morris RE
    Transplant Proc; 1997; 29(1-2):614-5. PubMed ID: 9123154
    [No Abstract]   [Full Text] [Related]  

  • 22. Delayed development of obliterative bronchiolitis syndrome with OKT3 after unilateral lung transplantation. A plea for multicenter immunosuppressive trials.
    Ross DJ; Jordan SC; Nathan SD; Kass RM; Koerner SK
    Chest; 1996 Apr; 109(4):870-3. PubMed ID: 8635362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Basiliximab as an alternative to antithymocyte globulin for early immunosuppression in lung transplantation.
    Clinckart F; Bulpa P; Jamart J; Eucher P; Delaunois L; Evrard P
    Transplant Proc; 2009 Mar; 41(2):607-9. PubMed ID: 19328937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation.
    Treede H; Glanville AR; Klepetko W; Aboyoun C; Vettorazzi E; Lama R; Bravo C; Knoop C; Aubert JD; Reichenspurner H;
    J Heart Lung Transplant; 2012 Aug; 31(8):797-804. PubMed ID: 22554673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic and exhaled cytokine and chemokine profiles are associated with the development of bronchiolitis obliterans syndrome.
    Kastelijn EA; Rijkers GT; Van Moorsel CH; Zanen P; Kwakkel-van Erp JM; Van De Graaf EA; Van Kessel DA; Grutters JC; Van Den Bosch JM
    J Heart Lung Transplant; 2010 Sep; 29(9):997-1008. PubMed ID: 20627628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tacrolimus (FK506) proves superior to OKT3 for treating episodes of persistent rejection following intrathoracic transplantation.
    Meiser BM; Uberfuhr P; Schulze C; Fuchs A; Mair H; Reichenspurner H; Kreuzer E; Reichart B
    Transplant Proc; 1997; 29(1-2):605-6. PubMed ID: 9123150
    [No Abstract]   [Full Text] [Related]  

  • 27. Lung transplantation in infants.
    Huddleston CB; Mendeloff EN
    Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu; 2001; 4():115-22. PubMed ID: 11460980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FK506 rescue therapy in lung transplantation.
    Wiebe K; Harringer W; Franke U; Strüber M; Krug N; Korff F; Wahlers T; Cremer J; Haverich A
    Transplant Proc; 1998 Jun; 30(4):1508-9. PubMed ID: 9636613
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhaled cyclosporine in lung transplantation.
    Verleden GM; Dupont LJ
    N Engl J Med; 2006 Apr; 354(16):1752-3; author reply 1752-3. PubMed ID: 16625016
    [No Abstract]   [Full Text] [Related]  

  • 30. Lung transplantation as the first choice in emphysema.
    Delgado M; Borro JM; De La Torre MM; Fernández R; González D; Paradela M; García JA; Fieira E; Rama P
    Transplant Proc; 2009; 41(6):2207-9. PubMed ID: 19715874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of prophylactic use of sirolimus on bronchiolitis obliterans syndrome development in lung transplant recipients.
    Sacher VY; Fertel D; Srivastava K; Panos A; Nguyen D; Baxter T; Shafazand S; Pham SM
    Ann Thorac Surg; 2014 Jan; 97(1):268-74. PubMed ID: 24119986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytolytic therapy for the bronchiolitis obliterans syndrome complicating lung transplantation.
    Snell GI; Esmore DS; Williams TJ
    Chest; 1996 Apr; 109(4):874-8. PubMed ID: 8635363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracorporeal photopheresis in lung transplantation.
    Astor TL; Weill D
    J Cutan Med Surg; 2003; 7(4 Suppl):20-4. PubMed ID: 12958704
    [No Abstract]   [Full Text] [Related]  

  • 34. Thoracic organ transplantation at Papworth Hospital.
    Milano CA; Buchan K; Perreas K; Wallwork J
    Clin Transpl; 1999; ():273-80. PubMed ID: 11038646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycophenolate mofetil in lung transplantation.
    Zuckermann A; Birsan T; Thaghavi S; Artemiou O; Kupilik N; Dekan G; Wolner E; Klepetko W
    Transplant Proc; 1998 Jun; 30(4):1514-6. PubMed ID: 9636616
    [No Abstract]   [Full Text] [Related]  

  • 36. Conservation of small-airway function by tacrolimus/cyclosporine conversion in the management of bronchiolitis obliterans following lung transplantation.
    Revell MP; Lewis ME; Llewellyn-Jones CG; Wilson IC; Bonser RS
    J Heart Lung Transplant; 2000 Dec; 19(12):1219-23. PubMed ID: 11124493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early treatment of acute rejection prevents chronic rejection in a rat model of allogenic left lung transplantation.
    Hirt SW; You XM; Möller F; Boeke K; Ernst M; Starke M; Spranger U; Wottge HU
    Transplant Proc; 1998 Jun; 30(4):1005-6. PubMed ID: 9636406
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome.
    Valentine VG; Gupta MR; Walker JE; Seoane L; Bonvillain RW; Lombard GA; Weill D; Dhillon GS
    J Heart Lung Transplant; 2009 Feb; 28(2):163-9. PubMed ID: 19201342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does bronchial artery revascularization influence results concerning bronchiolitis obliterans syndrome and/or obliterative bronchiolitis after lung transplantation?
    Nørgaard MA; Andersen CB; Pettersson G
    Eur J Cardiothorac Surg; 1998 Sep; 14(3):311-8. PubMed ID: 9761443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Azathioprine withdrawal in stable lung and heart/lung recipients receiving cyclosporine-based immunosuppression.
    Hoffmeyer F; Hoeper MM; Spiekerkötter E; Harringer W; Haverich A; Fabel H; Niedermeyer J
    Transplantation; 2000 Aug; 70(3):522-5. PubMed ID: 10949197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.